{"product_id":"iscucin-mali-strength-e-ampoules","title":"ISCUCIN mali Strength E Ampoules","description":"\u003ch1\u003e\u003cspan\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cem\u003eISCUCIN mali\u003c\/em\u003e\u003c\/span\u003e Strength E Ampoules\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp\u003e\u003cspan\u003ePack size:10 x 1 ml Dosage form:Ampoules\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cb\u003eIscucin Mali Strength E, liquid dilution for injection.\u003c\/b\u003e Active ingredient: Viscum album (Mali) e planta tota K. Indications: In accordance with anthroposophical understanding of man and nature. These include: In adults: Stimulation of formative and integrative forces for the dissolution and reintegration of independent growth processes, e.g. in malignant tumors, also with accompanying disorders of the blood-forming organs%%% in benign tumors%%% in defined precancerous conditions%%% Recurrence prevention after tumor operations%%% in chronic cross-border diseases (e.g. Crohn's disease%%% chronic joint diseases).\u003cbr\u003e\u003cbr\u003e\u003cb\u003eFor risks and side effects, read the package insert and ask your doctor or pharmacist.\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003ePACKAGE LEAFLET: INFORMATION FOR THE USER\u003cbr\u003e\u003cbr\u003eIscucin Mali Strength E, Liquid Dilution for Injection\u003cbr\u003eActive ingredient: Viscum album (Mali) e planta tota K\u003cbr\u003e\u003cbr\u003eComposition:\u003cbr\u003e1 ampoule contains: Viscum album (Mali) e planta tota K Dil. Strength E 1 ml (HAB, Vs. 38).\u003cbr\u003e\u003cbr\u003eIndications:\u003cbr\u003eAccording to the anthroposophical understanding of man and nature. These include: In adults: Stimulation of formative and integrative forces for the dissolution and reintegration of independent growth processes, e.g.\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003ein malignant tumor diseases, also with accompanying disorders of the blood-forming organs%%%\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ein benign tumor diseases%%%\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ewith defined precancerous conditions%%%\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eRecurrence prevention after tumor surgery%%%\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ein chronic cross-border diseases (e.g. Crohn's disease, chronic joint diseases).\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cbr\u003eContraindications:\u003cbr\u003eIscucin Mali should not be used in the following cases:\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eknown allergy to mistletoe preparations.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eacute inflammatory or high fever diseases, treatment should be interrupted until the signs of inflammation subside.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003echronic granulomatous diseases and florid autoimmune diseases and those under immunosuppressive therapy.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eHyperthyroidism with tachycardia.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cbr\u003ePrecautions for use and warnings:\u003cbr\u003ePrimary brain and spinal cord tumors or intracranial metastases with risk of increased intracranial pressure: In this case, the preparations should only be administered after strict indication and under close clinical supervision.\u003cbr\u003e\u003cbr\u003eWhat should you bear in mind during pregnancy and breastfeeding?\u003cbr\u003eThe effects of the drug on pregnancy, the development of the unborn child, childbirth, and the development of the child after birth, especially the development of blood cell formation and the immune system in the unborn child\/infant, have not been studied. The potential risk to humans is therefore unknown. Caution is advised when used during pregnancy and breastfeeding. Consult your doctor before using this medicine.\u003cbr\u003e\u003cbr\u003eAbility to drive and operate machinery:\u003cbr\u003eThere is no experience with regard to impairment of the ability to drive and operate machinery.\u003cbr\u003e\u003cbr\u003eInteractions with other medicinal products:\u003cbr\u003eThere are no studies on interactions with other immunomodulating substances (e.g. thymus extracts). When using such preparations close to the patient, careful dosing and monitoring of appropriate immune parameters is recommended.\u003cbr\u003e\u003cbr\u003eDosage and method of administration:\u003cbr\u003eThe dosage is always individualized according to the doctor's instructions.\u003cbr\u003e\u003cbr\u003eDuration of administration:\u003cbr\u003eThe treating physician decides on the duration of administration. In principle, there is no limit to the duration of administration. It is determined by the doctor and depends on the respective risk of relapse and the individual condition and findings of the patient. It should be several years, with breaks of increasing length generally being taken.\u003cbr\u003e\u003cbr\u003eMistakes in use:\u003cbr\u003eCaution is expressly emphasized regarding the need to increase the dosage. An excessive increase in the dosage, particularly when skipping a dilution level in the lower strengths (e.g., from strength C to strength E), can lead to allergic-like reactions that require emergency measures.\u003cbr\u003e\u003cbr\u003eSide effects:\u003cbr\u003eWhat side effects can occur when using Iscucin Mali?\u003cbr\u003eLike all medicines, Iscucin Mali can cause side effects, although not everyone will experience them. A slight increase in body temperature and local inflammatory reactions at the subcutaneous injection site almost always occur at the beginning of treatment and are signs of the patient's reaction. Temporary slight swelling of regional lymph nodes is also harmless. In cases of fever above 38°C (possibly with fatigue, chills, general malaise, headache, and brief dizziness) or in cases of larger local reactions exceeding 5 cm in diameter, the next injection should not be given until these symptoms have subsided and in a reduced strength or dose. The fever induced by Iscucin injection should not be suppressed with antipyretic drugs. If fever persists for more than three days, an infectious process or tumor fever should be considered. Excessive local reactions can be avoided by using a lower strength of the preparation or a lower dose. In this case, the use of 0.1–0.5 ml of the used strength using a graduated 1 ml syringe is recommended. Localized or systemic allergic or allergoid reactions may occur (usually in the form of generalized itching, urticaria, or rash, occasionally with Quincke's edema, chills, shortness of breath, and bronchospasticity, occasionally with shock or as erythema multiforme), which require discontinuation of the drug and initiation of medical treatment. Activation of pre-existing inflammation and inflammatory irritation of superficial veins in the injection area are possible. Here, too, a temporary break in therapy is required until the inflammatory reaction subsides. Chronic granulomatous inflammation (erythema nodosum) and autoimmune diseases (dermatomyositis) have been reported during mistletoe therapy. Symptoms of increased intracranial pressure in brain tumors\/metastases have also been reported during mistletoe therapy.\u003cbr\u003e\u003cbr\u003eContents:\u003cbr\u003e10 x 1 ml\u003cbr\u003e\u003cbr\u003ePharmaceutical entrepreneur and manufacturer:\u003cbr\u003eWALA Heilmittel GmbH\u003cbr\u003eDorfstraße 1\u003cbr\u003e73087 Bad Boll\/Eckwälden\u003cbr\u003e\u003cbr\u003eThis package leaflet was last revised in January 2025.\u003cbr\u003e\u003cbr\u003eSource: Information from the Wala catalogue\u003cbr\u003eas of: 04\/2025\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eActive ingredient: Viscum album (Mali) e planta tota K. Indications: According to anthroposophical understanding of man and nature. These include: In adults: Stimulation of formative and integrative forces for the dissolution and reintegration of independent growth processes, e.g. in malignant tumors, also with accompanying disorders of the blood-forming organs%%% in benign tumors%%% in defined precancerous conditions%%% Recurrence prevention after tumor surgery%%% in chronic cross-border diseases (e.g. Crohn's disease%%% chronic joint diseases).\u003c\/span\u003e\u003c\/p\u003e","brand":"WALA remedies GmbH","offers":[{"title":"Default Title","offer_id":55349675786613,"sku":"04428953","price":196.71,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0637\/3952\/7353\/files\/ISCUCINmaliStrengthEAmpoules.jpg?v=1746564669","url":"https:\/\/eliveragroup.co.uk\/products\/iscucin-mali-strength-e-ampoules","provider":"ELIVERA UK","version":"1.0","type":"link"}